Recent Finacing
Recent Raise
CytosinLab develops next-generation small-molecule epigenetic therapies and an EpigenPLUS R&D platform to modulate tumor and tumor‑microenvironment gene expression, advancing multiple preclinical programs toward INDs and collaborations.
